DYADIC INTERNATIONAL INC (DYAI) Form 10-K Annual Reports
DYADIC INTERNATIONAL INC (DYAI) is a publicly traded company on the Nasdaq, categorized under SIC 2836 (Biological Products, (No Diagnostic Substances)). Access real-time SEC filings, 10-K annual reports, 10-Q quarterlies, 8-K current reports, PCAOB auditor history, and executive compensation disclosures.
Ticker: DYAI
CIK: 1213809
Exchange: Nasdaq
SIC 2836: Biological Products, (No Diagnostic Substances)
Fiscal Year End: 12/31
State: DE
Independent PCAOB Auditor
Explore PCAOB Audit Intelligence →
Audit Firm
Crowe LLP
Auditor SinceSince 12/31/2023 12:00:00 AM
Lead Engagement PartnerMatthew Redente
Audit LocationLivingston, New Jersey, United States
Latest SEC EDGAR Filings
Showing 10-K, 10-Q, 8-K, Form 4, and other SEC submissions| Form | Filing Date | Reporting Period | Description | Accession Number | Actions |
|---|---|---|---|---|---|
| SCHEDULE 13G | 2026-10-15 | — | SCHEDULE 13G Filing | 0000919574-26-006982 | View SEC Doc Filr Page |
| 8-K | 2026-09-25 | 2026-09-25 | 8-K | 0001493152-26-044398 | View SEC Doc Filr Page |
| EFFECT | 2026-09-18 | — | EFFECT Filing | 9999999995-26-003013 | View SEC Doc Filr Page |
| 424B3 | 2026-09-18 | — | 424B3 | 0001493152-26-043416 | View SEC Doc Filr Page |
| S-1 | 2026-09-11 | — | S-1 | 0001493152-26-042435 | View SEC Doc Filr Page |
| SCHEDULE 13G/A | 2026-08-17 | — | SCHEDULE 13G/A Filing | 0001493152-26-038664 | View SEC Doc Filr Page |
| 8-K | 2026-08-14 | 2026-08-13 | 8-K | 0001493152-26-038039 | View SEC Doc Filr Page |
| 424B5 | 2026-08-13 | — | 424B5 | 0001493152-26-037870 | View SEC Doc Filr Page |
| 10-Q | 2026-08-12 | 2026-06-30 | 10-Q | 0001493152-26-037258 | View SEC Doc Filr Page |
| 8-K | 2026-08-12 | 2026-08-12 | 8-K | 0001493152-26-037257 | View SEC Doc Filr Page |
| 4 | 2026-07-24 | 2026-07-22 | 4 | 0001493152-26-034613 | View SEC Doc Filr Page |
| 8-K | 2026-07-24 | 2026-07-24 | 8-K | 0001493152-26-034475 | View SEC Doc Filr Page |
| 144 | 2026-07-21 | — | 144 Filing | 0001493152-26-034116 | View SEC Doc Filr Page |
| 4 | 2026-07-06 | 2024-03-08 | 4 | 0001493152-26-032062 | View SEC Doc Filr Page |
| SCHEDULE 13G/A | 2026-07-06 | — | SCHEDULE 13G/A Filing | 0001493152-26-032060 | View SEC Doc Filr Page |
| 8-K | 2026-06-22 | 2026-06-18 | 8-K | 0001493152-26-029504 | View SEC Doc Filr Page |
| DEFA14A | 2026-06-18 | — | DEFA14A | 0001493152-26-029215 | View SEC Doc Filr Page |
| 8-K | 2026-06-18 | 2026-06-18 | 8-K | 0001493152-26-029214 | View SEC Doc Filr Page |
| 8-K | 2026-06-15 | 2026-06-15 | 8-K | 0001493152-26-028700 | View SEC Doc Filr Page |
| 8-K | 2026-05-28 | 2026-05-28 | 8-K | 0001493152-26-025554 | View SEC Doc Filr Page |
| 8-K | 2026-05-13 | 2026-05-13 | 8-K | 0001493152-26-022727 | View SEC Doc Filr Page |
| 10-Q | 2026-05-13 | 2026-03-31 | 10-Q | 0001493152-26-022722 | View SEC Doc Filr Page |
| DEF 14A | 2026-05-12 | 2026-05-12 | DEF 14A | 0001493152-26-022505 | View SEC Doc Filr Page |
| SCHEDULE 13G/A | 2026-05-11 | — | SCHEDULE 13G/A Filing | 0001493152-26-022264 | View SEC Doc Filr Page |
| SCHEDULE 13G | 2026-05-11 | — | SCHEDULE 13G Filing | 0001493152-26-022259 | View SEC Doc Filr Page |